Cormorant Asset Management, LP

Average Profitability
<0.0001%
Insider Buys Quantity
21
Insider Buys Sum
$278.75M
Insider Sells Quantity
3
Insider Sells Sum
$3.91M

Insider Activity of Cormorant Asset Management, LP

According to the SEC Form 4 filings, Cormorant Asset Management, LP, being in a position of

  1. 10 percent owner at EyePoint Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 4794057 shares for $89.5M, and sold 0 shares,
    over all time since 2023-12-04, has bought 4794057 shares for $89.5M, and sold 0 shares.

The largest purchase of all time was on 2023-12-04 and amounted to 1919057 shares of EyePoint Pharmaceuticals, Inc. for $41.87M.

The largest sale of all time was on 2024-03-14 and amounted to 509091 share of Immuneering Corporation for $1.89M.

Biography of Cormorant Asset Management, LP

No biography is available at this moment.

2024-05-06PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
850,000
1.8064%
$11.86$10.08M-18.68%
2024-04-18PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
581,765
1.2029%
$18.03$10.49M-47.46%
2024-04-01SaleImmuneering Corporation
IMRX
10 percent owner
400,000
1.4407%
$2.90$1.16M-44.18%
2024-03-15SaleImmuneering Corporation
IMRX
10 percent owner
400,000
1.5312%
$2.14$856,400-18.85%
2024-03-14SaleImmuneering Corporation
IMRX
10 percent owner
509,091
1.0954%
$3.72$1.89M-46.21%
2024-01-11PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
750,000
2.0594%
$19.75$14.81M-42.3%
2024-01-09PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
105,000
0.2958%
$21.32$2.24M-44.78%
2023-12-08PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
588,235
1.4847%
$17.00$10M-14.27%
2023-12-04PurchaseEyePoint Pharmaceuticals, Inc.
EYPT
10 percent owner
1.92M
6.3418%
$21.82$41.87M-13.62%
2021-10-25PurchaseVentyx Biosciences, Inc.
VTYX
1.25M
8.2073%
$16.00$20M-16.24%
2021-10-13PurchasePyxis Oncology, Inc.
PYXS
450,000
1.9034%
$16.00$7.2M-70.72%
2021-09-17PurchaseTyra Biosciences, Inc.
TYRA
625,000
5.4808%
$16.00$10M-43.6%
2021-08-03PurchaseImmuneering Corporation
IMRX
550,000
2.3534%
$15.00$8.25M-47.84%
2021-07-02PurchaseAerovate Therapeutics, Inc.
AVTE
1M
2.9395%
$14.00$14M-34%
2021-06-29PurchaseElevation Oncology, Inc.
ELEV
250,000
30.0099%
$16.00$4M-56%
2021-06-28PurchaseMonte Rosa Therapeutics, Inc.
GLUE
600,000
11.7588%
$19.00$11.4M-7.95%
2021-06-21PurchaseVerve Therapeutics, Inc.
VERV
550,000
3.5535%
$19.00$10.45M-7.41%
2021-03-30PurchaseDesign Therapeutics, Inc.
DSGN
750,000
2.8822%
$20.00$15M-40.99%
2020-12-18PurchaseBioAtla, Inc.
BCAB
1.6M
2.4444%
$18.00$28.8M+17.46%
2020-11-23PurchaseOlema Pharmaceuticals, Inc.
OLMA
850,000
1.5181%
$19.00$16.15M-44.3%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.